Compare Crocs, Inc. (CROX) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crocs, Inc. vs 22nd Century Group Inc — how do they compare? Crocs, Inc. trades at $114.98 (market cap $5.60B), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: Crocs, Inc. is far larger — about 9008× 22nd Century Group Inc's market cap, and Crocs, Inc. is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Crocs, Inc. for 96 Days and 22nd Century Group Inc for 32 Days on average.
| CROX | XXII | |
|---|---|---|
Market Cap | $5.60B | $621.67K |
Volume | 1,026,773 | 45,625 |
Sector | Consumer Cyclical | Consumer Staples |
52-Week High | $141.19 | $483.00 |
52-Week Low | $73.39 | $0.80 |
Typical Hold Time | 96 Days | 32 Days |
Enterprise Value | $7.12B | -$3.69M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Crocs (CROX) trades at $116.84, up 1.42% with bearish technical signals but strong fundamentals including a low P/E of 10.37 and robust ROE of 42.3%. Recent earnings beats and a $136.78 analyst price target suggest upside potential despite negative net income in 2025. The company maintains solid cash flow generation and brand innovation focus.
The outlook remains positive with earnings momentum and valuation appeal, though risks include consumer spending volatility and HEYDUDE brand integration challenges. Analyst consensus leans bullish with 51% buy ratings, supporting potential recovery from current levels if execution improves.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Crocs, Inc.
Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable geographic segments of the company include Americas, Asia pacific, and EMEA.
Read more on CROX →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
